Search

Novartis AG

Slēgts

154.96 -1.07

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

154.74

Max

157.3

Galvenie mērījumi

By Trading Economics

Ienākumi

110M

3.3B

Pārdošana

894M

14B

P/E

Sektora vidējais

23.213

68.51

EPS

2.41

Dividenžu ienesīgums

3.04

Peļņas marža

22.654

Darbinieki

75,267

EBITDA

526M

5.9B

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+1.41% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

3.04%

2.29%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

6.7B

292B

Iepriekšējā atvēršanas cena

156.03

Iepriekšējā slēgšanas cena

154.96

Novartis AG Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. aug. 23:56 UTC

RingCentral Inc. shares advanced in after-market trading, continuing a month-long upward trend and remaining significantly above the 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Aramark shares are higher in after-market trading, recovering from an early decline. The stock remains below its 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Vir Biotechnology Inc. shares advanced in after-market trading, reflecting a modest increase from Monday's close, though still below the 20-day moving average.

2026. g. 10. aug. 23:56 UTC

CF Industries Holdings Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The stock is below its 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Yelp Inc. shares rose slightly in after-market trading, despite being below the 20-day moving average and near the lower end of their one-month range.

2026. g. 10. aug. 23:56 UTC

NN Inc shares are higher in after-market trading, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

2026. g. 10. aug. 23:56 UTC

Johnson Controls International PLC shares are higher in after-market trading, reflecting a modest uptick following Monday's close. The stock remains above its 20-day moving average.

2026. g. 10. aug. 23:56 UTC

B&G Foods Inc. shares are lower in after-market trading, reflecting broader market declines and cautious sentiment following recent labor market data.

2026. g. 10. aug. 23:56 UTC

Dynatrace Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment is influenced by recent economic data.

2026. g. 10. aug. 23:56 UTC

New Fortress Energy shares are higher in after-market trading, reaching 2.94% above Monday's close, significantly above the 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Social Media

NetApp Inc shares are trading higher in after-market hours following an upgrade from Morgan Stanley, driven by increased demand for storage solutions.

2026. g. 10. aug. 23:56 UTC

Ardelyx Inc shares are higher in after-market trading, despite no specific news driving the move. Recent market conditions include cautious optimism following a jobs report.

2026. g. 10. aug. 23:56 UTC

News

Iovance Biotherapeutics reported second-quarter revenue of $99.3 million, a 66% increase, contributing to a rise in shares during after-market hours.

2026. g. 10. aug. 23:56 UTC

Target Corp shares declined in after-market trading, reflecting a directional move since Monday's close. The stock remains above its 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Correlated Moves

Host Hotels & Resorts Inc. is trading lower in after-market hours, reflecting broader declines in small-cap stocks and cautious market sentiment following a recent jobs report.

2026. g. 10. aug. 23:56 UTC

Correlated Moves
ETF Constituents

Financial Select Sector SPDR Fund declines in after-market trading as top holdings Visa, FIS, and PayPal post losses amid flat U.S. markets.

2026. g. 10. aug. 23:56 UTC

Enovix Corp shares are higher in after-market trading, showing strength above their 20-day moving average amid cautious market optimism following recent labor data.

2026. g. 10. aug. 23:56 UTC

Correlated Moves

indie Semiconductor Inc's shares are lower in after-market hours, influenced by broader market caution and a decline in the Russell 2000 Index.

2026. g. 10. aug. 23:56 UTC

Hawaiian Electric Industries shares are lower in after-market hours, with no specific news identified. The stock remains below its 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Quantumscape Corp shares traded lower in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Tower Semiconductor shares are higher in after-market hours, with no specific news identified. The stock remains well above its 20-day moving average.

2026. g. 10. aug. 23:56 UTC

Correlated Moves

US 5Y Treasury Bond Index trades roughly flat as traders reassess September rate hike odds after a jobs report showed a decline of 23,000 jobs.

2026. g. 10. aug. 23:56 UTC

Correlated Moves

US 10Y Treasury Bond Index trades near unchanged as traders reassess September rate hike odds following a jobs report indicating a decline of 23,000 jobs.

2026. g. 10. aug. 23:52 UTC

Sarepta Therapeutics shares are lower in after-market hours, with no specific news identified for the decline amid broader market sentiment influenced by labor report data.

2026. g. 10. aug. 23:52 UTC

Correlated Moves
ETF Constituents
Macro News
Social Media

Energy Select Sector SPDR Fund lower in after-market hours despite crude oil prices rising to $82.25 amid concerns over the Strait of Hormuz reopening.

2026. g. 10. aug. 23:52 UTC

Event
News
Social Media

Plug Power shares are higher in after-market trading following strong second-quarter results that exceeded analyst expectations and an improved revenue growth outlook.

2026. g. 10. aug. 23:51 UTC

Modine Manufacturing Co shares are higher in after-market trading, buoyed by last Friday's labor report that reduced expectations for Federal Reserve rate hikes.

2026. g. 10. aug. 23:51 UTC

Correlated Moves

Stanley Black & Decker Inc shares declined in after-market trading amid weak market performance and downward pressure from recent labor market data.

2026. g. 10. aug. 23:51 UTC

Shoals Technologies Group Inc shares are lower in after-market trading. Broader market sentiment is affected by a recent labor report and Fed rate hike expectations.

2026. g. 10. aug. 23:51 UTC

Hilltop Holdings Inc is trading lower in after-market hours, continuing a decline since Monday's close amid broader market sentiment influenced by a weak labor report.

Salīdzinājums

Cenas izmaiņa

Novartis AG Prognoze

Cenas mērķis

By TipRanks

1.41% augšup

Prognoze 12 mēnešiem

Vidējais 159 USD  1.41%

Augstākais 180 USD

Zemākais 139 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Novartis AG — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

5 ratings

2

Pirkt

2

Turēt

1

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
help-icon Live chat